Further studies are warranted to elucidate the transcriptional regulation of TIMP3 by HIF-1α and to validate its role in vivo, which may contribute to the advancement of targeted therapeutic strategies for bladder cancer. This evidence concerns the gene HIF1A and urinary bladder carcinoma.